Randall Davis, PhD

Search results

• Studies from Oklahoma State University Yield New Information about Chemotherapy (A7 Nicotinic Acetylcholine Receptor Potentiation Downregulates Chemotherapy-induced Inflammatory Overactivation By Overlapping Intracellular Mechanisms)

  Davis, R. & Buck, D.

  12/12/23

  1 item of Media coverage

  Press/Media

• New OSU One Health Grant Program Spurs Research Collaboration

  Davis, R., Kaul, R., Kaul, A., Stephens, J., Das, S. & Ford, B.

  1/11/23 → 2/11/23

  2 items of Media coverage

  Press/Media

• NEW OSU ONE HEALTH GRANT PROGRAM SPURS RESEARCH COLLABORATION

  Davis, R., Kaul, R., Kaul, A., Stephens, J., Das, S. & Ford, B.

  1/11/23

  1 item of Media coverage

  Press/Media

• NEW OSU ONE HEALTH GRANT PROGRAM SPURS RESEARCH COLLABORATION

  Davis, R., Kaul, R., Kaul, A., Stephens, J., Das, S. & Ford, B.

  1/11/23

  1 item of Media coverage

  Press/Media

• University of Alabama: First-Ever Blazer Bridge Fund Grant Recipients Announced

  Davis, R.

  3/10/23

  1 item of Media coverage

  Press/Media

• First-ever Blazer Bridge Fund grant recipients announced

  Davis, R.

  2/10/23

  1 item of Media coverage

  Press/Media

• First-ever Blazer Bridge Fund grant recipients announced

  Davis, R.

  2/10/23

  1 item of Media coverage

  Press/Media

• Data on Chemotherapy Discussed by Researchers at Oklahoma State University (& Alpha;7 Nicotinic Acetylcholine Receptor Potentiation Downregulates Chemotherapy-induced Inflammatory Overactivation By Overlapping Intracellular Mechanisms)

  Davis, R. & Buck, D.

  21/08/23

  1 item of Media coverage

  Press/Media

• Progressively declining immune functions in individuals with chronic lymphocytic leukemia revealed by prospective study of immune responses to COVID vaccines between December 2020 and June 2021

  Davis, R.

  29/06/23

  1 item of Media coverage

  Press/Media

• Recent Findings in Inflammation Research Described by Researchers from Oklahoma State University Center for Health Sciences (Anti-inflammatory effects of b-FNA are sex-dependent in a pre-clinical model of LPS-induced inflammation)

  Davis, R., Buck, D. & McCracken, K.

  10/02/23

  1 item of Media coverage

  Press/Media

• Alabama physicians back school leaders who listen to public health experts

  Davis, R.

  23/08/21

  3 items of Media coverage

  Press/Media

• Physicians back school leaders who listen to public health experts

  Davis, R.

  23/08/21

  1 item of Media coverage

  Press/Media

• LSU Health Sciences Center honors graduates from six professional health schools

  Davis, R.

  12/07/21

  1 item of Media coverage

  Press/Media

• Convalescent Plasma Therapy Treats Severe COVID-19 In Immunocompromised Patient

  Davis, R.

  24/01/21

  1 item of Media coverage

  Press/Media

• Infusion of convalescent blood plasma benefits patient with severe COVID-19

  Davis, R.

  22/01/21

  2 items of Media coverage

  Press/Media

• University of Alabama Birmingham: COVID-19 Infection in Immunodeficient Patient Cured by Infusing Convalescent Plasma

  Davis, R.

  22/01/21

  1 item of Media coverage

  Press/Media

• COVID-19 infection in immunodeficient patient cured by infusing convalescent plasma, doctors report — ScienceDaily

  Davis, R.

  22/01/21

  1 item of Media coverage

  Press/Media

• COVID-19 infection in immunodeficient patient cured by infusing convalescent plasma

  Davis, R.

  21/01/21

  1 item of Media coverage

  Press/Media

• COVID-19 infection in immunodeficient patient cured by infusing convalescent plasma

  Davis, R.

  21/01/21

  5 items of Media coverage

  Press/Media

• OSU/A&M REGENTS APPROVE PERSONNEL ACTIONS

  Cotton, L., Blankenship, D., Wheeler, D., Stroup, J., Volberding, J., Davis, R., Manjarrez, J., Lane, A. & Wymore, R.

  11/09/20

  1 item of Media coverage

  Press/Media